Sonnet BioTherapeutics I...
(SONN)
undefined
undefined%
At close: undefined
1.87
-1.84%
Pre-market Jan 07, 2025, 06:16 AM EST
Ratios (Annual)
Discover comprehensive ratio statement breakdowns that reveal insights into revenue, expenses, and beyond.
| Year | FY24 | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 | FY16 | FY15 | FY14 | FY13 | FY12 | FY11 | FY10 | FY09 | FY08 | FY07 |
| PE Ratio | -0.59 | -1.26 | -1.71 | -4.75 | -6.23 | -7.99 | -5.29 | -7.8 | -8.03 | -15 | n/a | -50.39 | -1.87M | -10.18M | -15.54 | -4.74 | -2.34 | n/a |
| PS Ratio | 235.35 | 160.99 | 145.84 | 245.82 | n/a | 0.99 | 1.18 | 1.28 | 1.75 | 4.29 | n/a | 17.17 | 861.11K | 7.68M | 115.34 | 5.63 | 22.38 | n/a |
| PB Ratio | -9.02 | -105.3 | -20.1 | 5.34 | 64.07 | -14.13 | 4.88 | 4.95 | 5.69 | 8.37 | n/a | 26.73 | 1.07M | 6.85M | 0.19 | 5.37 | 3.40 | n/a |
| P/FCF Ratio | -0.51 | -1.09 | -1.79 | -5.27 | -12.33 | -8.7 | -12.91 | -22.56 | -42.87 | -25.42 | -71.18 | -46.97 | -1.68M | -7.84M | -20.55 | -5.99 | -6.15 | n/a |
| P/OCF Ratio | -0.51 | -1.11 | -1.84 | -5.27 | -12.39 | -18.06 | -32.67 | -73.19 | -143.17 | -33.94 | -210.9 | -109.75 | -2.52M | -10.76M | -20.68 | -6.06 | -6.16 | n/a |
| OCF/S Ratio | -462.13 | -144.39 | -79.12 | -46.63 | n/a | -0.05 | -0.04 | -0.02 | -0.01 | -0.13 | n/a | -0.16 | -0.34 | -0.71 | -5.58 | -0.93 | -3.63 | n/a |
| Debt / Equity Ratio | n/a | n/a | -0.00 | 0.00 | 0.05 | -0.08 | 1.39 | 0.90 | 0.81 | 0.43 | n/a | 0.07 | 0.05 | 1.87 | 11.36 | 0.57 | 0.32 | 0.05 |
| Quick Ratio | 0.66 | 0.86 | 0.75 | 4.30 | 1.62 | -0.15 | 0.08 | 0.09 | 0.10 | 0.19 | n/a | 0.24 | 1.02 | 0.16 | 0.25 | 0.10 | 0.03 | 0.06 |
| Current Ratio | 0.66 | 0.86 | 0.66 | 4.30 | 1.62 | 0.01 | 0.10 | 0.12 | 0.15 | 0.24 | n/a | 0.31 | 1.15 | 0.17 | 0.25 | 0.10 | 0.03 | 0.06 |
| Asset Turnover | 0.01 | 0.03 | 0.06 | 0.02 | n/a | 1.02K | 1.03 | 1.37 | 1.25 | 1.00 | n/a | 0.87 | 0.90 | 0.27 | 0.00 | 0.47 | 0.11 | n/a |
| Interest Coverage | n/a | n/a | n/a | n/a | -1.17K | -28.91 | -8.05 | 0.97 | 1.12 | 3.31 | n/a | n/a | 6.04 | 3.95 | -5.78 | -13.11 | -46.37 | n/a |
| Return on Equity (ROE) | 15.31 | 83.34 | 11.73 | -1.12 | -10.29 | 1.77 | -0.92 | -0.63 | -0.71 | -0.56 | n/a | -0.53 | -0.57 | -0.67 | -0.01 | -1.13 | -1.45 | n/a |
| Return on Assets (ROA) | -2.68 | -3.47 | -5.11 | -0.86 | -3.89 | -126.63 | -0.23 | -0.23 | -0.27 | -0.29 | n/a | -0.3 | -0.41 | -0.2 | -0.00 | -0.56 | -1.01 | n/a |
| Return on Capital (ROIC) | 26.98 | 197.57 | 12.71 | -1.13 | -7.41 | 1.65 | -0.18 | -0.16 | -0.12 | -0.44 | n/a | -0.4 | -0.49 | -0.38 | -0.00 | -0.54 | -0.61 | n/a |
| Dividend Yield | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Payout Ratio | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Gross Profit Margin | 100.00% | -7.89K% | 73.35% | -3.34K% | n/a | 80.47% | 2.57% | 4.89% | 7.98% | 66.89% | n/a | 100.00% | 59.87% | 75.35% | 91.87% | n/a | n/a | n/a |
| Net Profit Margin | -39.93K% | -12.74K% | -8.51K% | -5.17K% | n/a | -12.4% | -22.3% | -16.4% | -21.77% | -28.63% | n/a | -34.07% | -46.01% | -75.38% | -742.16% | -118.84% | -956.45% | n/a |
| Pretax Profit Margin | -39.93K% | -12.74K% | -8.49K% | -5.17K% | n/a | -11.99% | -26.26% | -18.85% | -9.95% | -33.78% | n/a | -34.07% | -49.04% | -74.75% | -755.62% | -118.84% | -956.45% | n/a |
| Operating Profit Margin | -63.62K% | -12.71K% | -8.48K% | -5.19K% | n/a | -11.59% | -9.99% | -6.08% | -6.28% | -27.1% | n/a | -33.13% | -41.69% | -48.8% | -594.19% | -64.92% | -405.88% | n/a |
| FCF Margin | -46.21K% | -14.74K% | -8.17K% | -4.66K% | n/a | -11.37% | -9.14% | -5.67% | -4.08% | -16.89% | n/a | -36.55% | -51.25% | -97.86% | -561.13% | -94.05% | -363.9% | n/a |
| EBITDA Margin | -63.62K% | -12.66K% | -8.45K% | -5.17K% | n/a | -32.38% | -12.06% | -7.08% | 1.30% | -6.44% | n/a | -22.33% | -47.06% | -80.75% | -644.76% | -54.92% | -942.91% | n/a |